Eyegate Pharma (EYEG) Secures New Patent for Iontophoretic Contact Lens Technology
Tweet Send to a Friend
EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) today announced that the United States Patent and Trademark Office (USPTO) has issued the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
